AzTrials
AzTrials

Chronic PeriodontitisNCT04047212

The Link Between Periodontitis, Smoking and Oral Cancer

An observational study of Chronic Periodontitis and Oral Cancer, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Periodontitis is a widely prevalent disease worldwide that has serious public health consequences. Its prognosis includes tooth loss and edentulism, a condition that negatively affects chewing causing functional disability; and esthetics causing social impairment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Periodontitis, Oral Cancer
What is being tested?
biopsy for oral cancer and periodontal examination
Type of treatment
Pill or oral medicine
How many people
200 participants
Where
1 siteEgypt
Study dates
12 Aug 2021to 30 Jan 2032
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult individuals

Who may be able to join

  • Patients 18 years or older.

Who cannot join

  • Patients with any systemic diseases.
  • Pregnant females.
  • Handicapped and mentally retarded patients.
  • Patients undergoing radiotherapy.
  • Patients having oral cancer

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayat Gamal-AbdelNaser contact

01001874257

ayat.gamal@dentistry.cu.edu.eg

Egypt1 site
  • Cairo University

    Cairo, 11562

    Ayat A Gamal-AbdelNaser, 01001874257, ayat.gamal@dentistry.cu.edu.eg

Other trials in Egypt

About this study

Official title: Analysis of the Link Between Periodontitis, Smoking and Oral Cancer: Cohort Study

Periodontitis is a widely prevalent disease worldwide that has serious public health consequences. Its prognosis includes tooth loss and edentulism, a condition that negatively affects chewing causing functional disability; and esthetics causing social impairment. Consequently, periodontitis may end up causing marked impairment of the quality of life of the affected patients, impairment of general health and increasing the dental care costs significantly.

Changes in the oral mucosa arise by primary products resulting from tissue breakdown due to gingivitis. It then triggers the host cells to produce proteinases that mediate loss of marginal periodontal ligaments, apical migration of the junctional epithelium and apical spread of bacterial biofilm.

Therefore, this research aims to identify the risk of smoking to both periodontitis and oral cancer, and the risk of periodontitis to oral cancer.

Being tested
biopsy for oral cancer, periodontal examination
Medical subject headings
Chronic Periodontitis, Mouth Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • biopsy for oral cancerDiagnostic test

    surgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions

  • periodontal examinationDiagnostic test

    Periodontal clinical examination to all by periodontal charting

Study groups in NCT04047212
Study groupRoleWhat they receive
SmokersNot described
Receives: Diagnostic Test: biopsy for oral cancer; Diagnostic Test: periodontal examination
non-SmokersNot described
Receives: Diagnostic Test: biopsy for oral cancer; Diagnostic Test: periodontal examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Periodontitis

    arising of periodontitis or increase in the grade of an already existing case of periodontitis

    Measured: the 10 years of the study

Secondary outcomes (1)
  1. Oral cancer

    Arising of a lesion of oral cancer or a premalignant lesion

    Measured: the 10 years of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2019
  2. Study start12 Aug 2021 (estimated)
  3. Primary completion12 Oct 2031 (estimated)
  4. Study completion30 Jan 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04047212
Sponsor's protocol ID
P12
Status last verified
Jun 2021
First submitted
3 Aug 2019
Last updated
16 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Periodontitis and Oral Cancer, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayat Gamal-AbdelNaser (01001874257, ayat.gamal@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Periodontitis (time frame: the 10 years of the study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in